Wooten M: Systemic sclerosis and malignancy: a review of the literature. South Med J. 2008, 101: 59-62. 10.1097/SMJ.0b013e31815838ce.
Article
PubMed
Google Scholar
Colaci M, Giuggioli D, Sebastiani M, Manfredi A, Vacchi C, Spagnolo P, Cerri S, Luppi F, Richeldi L, Ferri C: Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. Autoimmun Rev. 2013, 12: 374-379. 10.1016/j.autrev.2012.06.003.
Article
PubMed
Google Scholar
Abu-Shakra M, Guillemin F, Lee P: Cancer in systemic sclerosis. Arthritis Rheum. 1993, 36: 460-464. 10.1002/art.1780360405.
Article
CAS
PubMed
Google Scholar
Hashimoto A, Arinuma Y, Nagai T, Tanaka S, Matsui T, Tohma S, Endo H, Hirohata S: Incidence and the risk factor of malignancy in Japanese patients with systemic sclerosis. Intern Med. 2012, 51: 1683-1688. 10.2169/internalmedicine.51.7686.
Article
PubMed
Google Scholar
Marasini B, Conciato L, Belloli L, Massarotti M: Systemic sclerosis and cancer. Int J Immunopathol Pharmacol. 2009, 22: 573-578.
CAS
PubMed
Google Scholar
Szekanecz É, Szamosi S, Horváth Á, Németh Á, Juhász B, Szántó J, Szücs G, Szekanecz Z: Malignancies associated with systemic sclerosis. Autoimmun Rev. 2012, 11: 852-855. 10.1016/j.autrev.2012.02.021.
Article
CAS
PubMed
Google Scholar
Airò P, Ceribelli A, Cavazzana I, Taraborelli M, Zingarelli S, Franceschini F: Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies. J Rheumatol. 2011, 38: 1329-1334. 10.3899/jrheum.101144.
Article
PubMed
Google Scholar
Shah AA, Rosen A, Hummers L, Wigley F, Casciola-Rosen L: Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies. Arthritis Rheum. 2010, 62: 2787-2795. 10.1002/art.27549.
Article
PubMed
PubMed Central
Google Scholar
Ichimura Y, Matsushita T, Hamaguchi Y, Kaji K, Hasegawa M, Tanino Y, Inokoshi Y, Kawai K, Kanekura T, Habuchi M, Igarashi A, Sogame R, Hashimoto T, Koga T, Nishino A, Ishiguro N, Sugimoto N, Aoki R, Ando N, Abe T, Kanda T, Kuwana M, Takehara K, Fujimoto M: Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy. Ann Rheum Dis. 2012, 71: 710-713. 10.1136/annrheumdis-2011-200697.
Article
CAS
PubMed
Google Scholar
Trallero-Araguás E, Labrador-Horrillo M, Selva-O’Callaghan A, Martínez MA, Martínez-Gómez X, Palou E, Rodriguez-Sanchez JL, Vilardell-Tarrés M: Cancer-associated myositis and anti-p155 autoantibody in a series of 85 patients with idiopathic inflammatory myopathy. Medicine (Baltimore). 2010, 89: 47-52. 10.1097/MD.0b013e3181ca14ff.
Article
Google Scholar
LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Rowell N, Wollheim F: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988, 15: 202-205.
CAS
PubMed
Google Scholar
LeRoy EC, Medsger TA: Criteria for the classification of early systemic sclerosis. J Rheumatol. 2001, 28: 1573-1576.
CAS
PubMed
Google Scholar
Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980, 23: 581-590. 10.1002/art.1780230510.
Article
Google Scholar
Shand L, Lunt M, Nihtyanova S, Hoseini M, Silman A, Black CM, Denton CP: Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model. Arthritis Rheum. 2007, 56: 2422-2431. 10.1002/art.22721.
Article
PubMed
Google Scholar
Nihtyanova SI, Denton CP: Autoantibodies as predictive tools in systemic sclerosis. Nat Rev Rheumatol. 2010, 6: 112-116. 10.1038/nrrheum.2009.238.
Article
CAS
PubMed
Google Scholar
Nihtyanova SI, Parker JC, Black CM, Bunn CC, Denton CP: A longitudinal study of anti-RNA polymerase III antibody levels in systemic sclerosis. Rheumatology (Oxford). 2009, 48: 1218-1221. 10.1093/rheumatology/kep215.
Article
CAS
Google Scholar
Steen VD: Autoantibodies in systemic sclerosis. Semin Arthritis Rheum. 2005, 35: 35-42. 10.1016/j.semarthrit.2005.03.005.
Article
CAS
PubMed
Google Scholar
Penn H, Howie AJ, Kingdon EJ, Bunn CC, Stratton RJ, Black CM, Burns A, Denton CP: Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM. 2007, 100: 485-494. 10.1093/qjmed/hcm052.
Article
CAS
PubMed
Google Scholar
Statistics with Confidence: Confidence Intervals and Statistical Guidelines. Edited by: Altman D, Machin D, Bryant T, Gardner S. 2000, Chichester, UK: Wiley-Blackwell/BMJ Books, 2
Google Scholar
Bonifazi M, Tramacere I, Pomponio G, Gabrielli B, Avvedimento EV, La Vecchia C, Negri E, Gabrielli A: Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies. Rheumatology (Oxford). 2013, 52: 143-154. 10.1093/rheumatology/kes303.
Article
Google Scholar
Launay D, Le Berre R, Hatron PY, Peyrat JP, Hachulla E, Devulder B, Hebbar M: Association between systemic sclerosis and breast cancer: eight new cases and review of the literature. Clin Rheumatol. 2004, 23: 516-522. 10.1007/s10067-004-0940-5.
Article
PubMed
Google Scholar
Levine SM: Cancer and myositis: new insights into an old association. Curr Opin Rheumatol. 2006, 18: 620-624. 10.1097/01.bor.0000245721.02512.77.
Article
CAS
PubMed
Google Scholar
Bernatsky S, Boivin JF, Joseph L, Rajan R, Zoma A, Manzi S, Ginzler E, Urowitz M, Gladman D, Fortin PR, Petri M, Edworthy S, Barr S, Gordon C, Bae SC, Sibley J, Isenberg D, Rahman A, Aranow C, Dooley MA, Steinsson K, Nived O, Sturfelt G, Alarcón G, Senécal JL, Zummer M, Hanly J, Ensworth S, Pope J, El-Gabalawy H, McCarthy T, St Pierre Y, Ramsey-Goldman R, Clarke A: An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum. 2005, 52: 1481-1490. 10.1002/art.21029.
Article
CAS
PubMed
Google Scholar
Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, Evans SR, Felson DT: Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001, 357: 96-100. 10.1016/S0140-6736(00)03540-6.
Article
CAS
PubMed
Google Scholar
Chen W, Böcker W, Brosius J, Tiedge H: Expression of neural BC200 RNA in human tumours. J Pathol. 1997, 183: 345-351. 10.1002/(SICI)1096-9896(199711)183:3<345::AID-PATH930>3.0.CO;2-8.
Article
CAS
PubMed
Google Scholar
Felton-Edkins ZA, White RJ: Multiple mechanisms contribute to the activation of RNA polymerase III transcription in cells transformed by papovaviruses. J Biol Chem. 2002, 277: 48182-48191. 10.1074/jbc.M201333200.
Article
CAS
PubMed
Google Scholar
Larminie CG, Sutcliffe JE, Tosh K, Winter AG, Felton-Edkins ZA, White RJ: Activation of RNA polymerase III transcription in cells transformed by simian virus 40. Mol Cell Biol. 1999, 19: 4927-4934.
Article
CAS
PubMed
PubMed Central
Google Scholar
White RJ: RNA polymerases I and III, growth control and cancer. Nat Rev Mol Cell Biol. 2005, 6: 69-78. 10.1038/nrm1551.
Article
CAS
PubMed
Google Scholar
Kenneth NS, Ramsbottom BA, Gomez-Roman N, Marshall L, Cole PA, White RJ: TRRAP and GCN5 are used by c-Myc to activate RNA polymerase III transcription. Proc Natl Acad Sci U S A. 2007, 104: 14917-14922. 10.1073/pnas.0702909104.
Article
CAS
PubMed
PubMed Central
Google Scholar
Domsic RT, Medsger TA: Disease subsets in clinical practice. Scleroderma: From Pathogenesis to Comprehensive Management. Edited by: Varga J, Denton CP, Wigley FM. 2012, New York: Springer, 45-52.
Chapter
Google Scholar
Moinzadeh P, Nihtyanova SI, Howell K, Ong VH, Denton CP: Impact of hallmark autoantibody reactivity on early diagnosis in scleroderma. Clin Rev Allergy Immunol. 2012, 43: 249-255. 10.1007/s12016-012-8331-1.
Article
CAS
PubMed
Google Scholar
Rosenthal AK, McLaughlin JK, Gridley G, Nyrén O: Incidence of cancer among patients with systemic sclerosis. Cancer. 1995, 76: 910-914. 10.1002/1097-0142(19950901)76:5<910::AID-CNCR2820760528>3.0.CO;2-T.
Article
CAS
PubMed
Google Scholar
Roumm AD, Medsger TA: Cancer and systemic sclerosis: an epidemiologic study. Arthritis Rheum. 1985, 28: 1336-1340. 10.1002/art.1780281204.
Article
CAS
PubMed
Google Scholar
Yang Y, Fujita J, Tokuda M, Bandoh S, Ishida T: Lung cancer associated with several connective tissue diseases: with a review of literature. Rheumatol Int. 2001, 21: 106-111. 10.1007/s00296-001-0141-3.
Article
CAS
PubMed
Google Scholar
Peters-Golden M, Wise RA, Hochberg M, Stevens MB, Wigley FM: Incidence of lung cancer in systemic sclerosis. J Rheumatol. 1985, 12: 1136-1139.
CAS
PubMed
Google Scholar
Halpert RD, Laufer I, Thompson JJ, Feczko PJ: Adenocarcinoma of the esophagus in patients with scleroderma. AJR Am J Roentgenol. 1983, 140: 927-930. 10.2214/ajr.140.5.927.
Article
CAS
PubMed
Google Scholar
Katzka DA, Reynolds JC, Saul SH, Plotkin A, Lang CA, Ouyang A, Jimenez S, Cohen S: Barrett’s metaplasia and adenocarcinoma of the esophagus in scleroderma. Am J Med. 1987, 82: 46-52. 10.1016/0002-9343(87)90376-7.
Article
CAS
PubMed
Google Scholar
Hill CL, Nguyen AM, Roder D, Roberts-Thomson P: Risk of cancer in patients with scleroderma: a population based cohort study. Ann Rheum Dis. 2003, 62: 728-731. 10.1136/ard.62.8.728.
Article
CAS
PubMed
PubMed Central
Google Scholar
Onishi A, Sugiyama D, Kumagai S, Morinobu A: Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies. Arthritis Rheum. 1913–1921, 2013: 65-
Google Scholar
Forbes AM, Woodrow JC, Verbov JL, Graham RM: Carcinoma of breast and scleroderma: four further cases and a literature review. Br J Rheumatol. 1989, 28: 65-69. 10.1093/rheumatology/28.1.65.
Article
CAS
PubMed
Google Scholar
Hassett G, Harnett P, Manolios N: Scleroderma in association with the use of docetaxel (taxotere) for breast cancer. Clin Exp Rheumatol. 2001, 19: 197-200.
CAS
PubMed
Google Scholar
Mirone L, Barini A: Androgen and prolactin (Prl) levels in systemic sclerosis (SSc): relationship to disease severity. Ann NY Acad Sci. 2006, 1069: 257-262. 10.1196/annals.1351.023.
Article
CAS
PubMed
Google Scholar
Straub RH, Zeuner M, Lock G, Schölmerich J, Lang B: High prolactin and low dehydroepiandrosterone sulphate serum levels in patients with severe systemic sclerosis. Br J Rheumatol. 1997, 36: 426-432. 10.1093/rheumatology/36.4.426.
Article
CAS
PubMed
Google Scholar
López-Marure R, Contreras PG, Dillon JS: Effects of dehydroepiandrosterone on proliferation, migration, and death of breast cancer cells. Eur J Pharmacol. 2011, 660: 268-274. 10.1016/j.ejphar.2011.03.040.
Article
PubMed
Google Scholar
Qian N, Ueno T: Is dysfunction of caveolin-1 a link between systemic sclerosis and breast cancer, opening a window on both etiologies?. Arch Med Res. 2010, 41: 297-301. 10.1016/j.arcmed.2010.05.009.
Article
CAS
PubMed
Google Scholar
Lei W, Luo Y, Lei W, Luo Y, Yan K, Zhao S, Li Y, Qiu X, Zhou Y, Long H, Zhao M, Liang Y, Su Y, Lu Q: Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol. 2009, 38: 369-374. 10.1080/03009740902758875.
Article
CAS
PubMed
Google Scholar